Company Mycenax Biotech Inc.

Equities

4726

TW0004726005

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
43.45 ^TWD	-0.23%		-6.16%	+21.71%

Mar. 14	Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 13	Mycenax Biotech Inc. Announces the Appointment of Li-Ju Yeh as Corporate Governance Officer	CI

Mycenax Biotech Inc. is a Taiwan-based company principally engaged in the development and manufacture of pharmaceutical products. Its products are derived from mammalian cell culture and microbial fermentation. Its products include TuNEX, LusiNEX, GranNEX and AiNEX. Its products are applied in treatment of brain cancer, psoriasis and renal cell carcinoma, among others. The Company is also engaged in the provision of chemical, manufacturing and control (CMC) technology and the operation of a current good manufacture practice (cGMP) biopharmaceutical factory. The Company mainly operates its products within domestic market and to overseas markets.

Number of employees: 387

TWD in Million	2022	Weight	2023	Weight	Delta
Technology Service 99.8 %	615	84.0 %	652	99.8 %	+5.96%
Other 0.2 %	117	16.0 %	1	0.2 %	-99.05%

TWD in Million	2022	Weight	2023	Weight	Delta
Asia 75.7 %	326	44.5 %	494	75.7 %	+51.66%
Taiwan 23.9 %	278	38.0 %	156	23.9 %	-43.87%
Americas 0.4 %	7	1.0 %	3	0.4 %	-61.56%

Managers	Title	Age	Since
Pei Chun Chen CEO	Chief Executive Officer	-	19-02-28
Wan Tzu Chang DFI	Director of Finance/CFO	-	19-04-07
Wei Yi Chou CTO	Chief Tech/Sci/R&D Officer	-	19-05-12

Members of the board	Title	Age	Since
Kuo Pin Kao BRD	Director/Board Member	-	13-03-27
Wan Lai Cheng BRD	Director/Board Member	-	11-05-17
Sandy Lee BRD	Director/Board Member	-	19-08-14
Chun Hung Chen BRD	Director/Board Member	69	06-06-19
Man Chin Ku BRD	Director/Board Member	-	13-06-23
Chia Ling Lin BRD	Director/Board Member	-	19-08-14
Shu Hsuan Tsai BRD	Director/Board Member	-	17-06-14
Yue Sheng Tsai BRD	Director/Board Member	-	19-08-14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	205,722,200	97,738,200 ( 47.51 %)	0	47.51 %

Mycenax Biotech, Inc.

2/F 8 Kedung 3rd Road

350 53, Miaoli

http://www.mycenax.com.tw

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
MYCENAX BIOTECH INC.	+21.99%	275M
VERTEX PHARMACEUTICALS INCORPORATED	-2.63%	102B
REGENERON PHARMACEUTICALS, INC.	+1.62%	96.29B
ARGENX SE	+2.36%	22.18B
BIONTECH SE	-16.67%	21.2B
GENMAB A/S	-9.16%	18.31B
WUXI APPTEC CO., LTD.	-38.74%	17.38B
BEIGENE, LTD.	-13.21%	16.36B
NEUROCRINE BIOSCIENCES, INC.	+5.41%	13.97B
SAREPTA THERAPEUTICS, INC.	+33.57%	12.17B

Bio Therapeutic Drugs